Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 52,858 | 20,021 | 15,177 | 12,163 | 18,904 |
| Operating Income | -52,858 | -20,021 | -15,177 | -12,163 | -18,904 |
| Interest Expense | 3,091 | 4,989 | 3,684 | 904 | 301 |
| Other Income | 1,939 | 1,181 | 272 | 5 | 7 |
| Pre-tax Income | -54,010 | -23,829 | -18,589 | -13,062 | -19,198 |
| Income Tax | -4,393 | 271 | 0 | N/A | N/A |
| Net Income Continuous | -49,617 | -24,100 | -18,589 | -13,062 | -19,198 |
| Net Income | $-49,617 | $-24,100 | $-18,589 | $-13,062 | $-19,198 |
| EPS Basic Total Ops | -4.08 | -59.72 | -47.31 | -531.32 | -781.82 |
| EPS Basic Continuous Ops | -4.08 | -59.72 | -47.31 | -531.34 | -781.79 |
| EPS Diluted Total Ops | -4.08 | -59.72 | -47.31 | -531.32 | -781.82 |
| EPS Diluted Continuous Ops | -4.08 | -59.72 | -47.31 | -531.34 | -781.79 |
| EPS Diluted Before Non-Recurring Items | -4.08 | -537.53 | -41.31 | -531.32 | N/A |
| EBITDA(a) | $-34,439 | $-17,946 | $-13,082 | $-11,686 | $-18,419 |